Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.

MLA

Parodi, Emilia, et al. “Long-Term Follow-up Analysis after Rituximab Therapy in Children with Refractory Symptomatic ITP: Identification of Factors Predictive of a Sustained Response.” British Journal of Haematology, vol. 144, no. 4, Feb. 2009, pp. 552–58. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2008.07487.x.

APA

Parodi, E., Rivetti, E., Amendola, G., Bisogno, G., Calabrese, R., Farruggia, P., Giordano, P., Matarese, S. M. R., Nardi, M., Nobili, B., Notarangelo, L. D., Russo, G., Vimercati, C., Zecca, M., De Mattia, D., & Ramenghi, U. (2009). Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response. British Journal of Haematology, 144(4), 552–558. https://doi.org/10.1111/j.1365-2141.2008.07487.x

Chicago

Parodi, Emilia, Elisa Rivetti, Giovanni Amendola, Gianni Bisogno, Roberto Calabrese, Piero Farruggia, Paola Giordano, et al. 2009. “Long-Term Follow-up Analysis after Rituximab Therapy in Children with Refractory Symptomatic ITP: Identification of Factors Predictive of a Sustained Response.” British Journal of Haematology 144 (4): 552–58. doi:10.1111/j.1365-2141.2008.07487.x.